Intravenous Treatment of Hyperhomocysteinemia in Patients on Chronic Hemodialysis—A Pilot Study

References

• Mallamaci F., Zoccali C., Tripepi G., Fermo I., Benedetto F. A., Cataliotti A., Bellanuova I., Malatino L. S., Soldarini A. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002; 61(2)609–614, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moustapha A., Naso A., Nahlawi M., Gupta A., Arheart K. L., Jacobsen D. W., Robinson K., Dennis V. W. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end‐stage renal disease. Circulation 1998; 97(2)138–141, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Woodside J. V., Yarnell J. W., McMaster D., Young I. S., Harmon D. L., McCrum E. E., Patterson C. C., Gey K. F., Whitehead A. S., Evans A. Effect of B‐group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double‐blind, randomized, factorial‐design, controlled trial. Am. J. Clin. Nutr. 1998; 67(5)858–866, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Culleton B. F. Hyperhomocysteinemia in chronic renal disease. J. Am. Soc. Nephrol. 1999; 10(4)891–900, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Look M. P., Riezler R., Reichel C., Brensing K. A., Rockstroh J. K., Stabler S. P., Spengler U., Berthold H. K., Sauerbruch T. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma‐cystathionase?. Scand. J. Gastroenterol. 2000; 35(8)866–872, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van Guldener C., Kulik W., Berger R., Dijkstra D. A., Jakobs C., Reijngoud D. J., Donker A. J., Stehouwer C. D., De Meer K. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int. 1999; 56(3)1064–1071, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dierkes J., Domrose U., Ambrosch A., Bosselmann H. P., Neumann K. H., Luley C. Response of hyperhomocysteinemia to folic acid supplementation in patients with end‐stage renal disease. Clin. Nephrol. 1999; 51(2)108–115, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Shemin D., Lapane K. L., Hume A. L., Yoburn D., Nadeau M. R., Bendich A., Selhub J., Rosenberg I. H. High dose‐B‐vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996; 49(1)147–152, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thambyrajah J., Landray M. J., McGlynn F. J., Jones H. J., Wheeler D. C., Townend J. N. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?. Circulation 2000; 102(8)871–875, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sombolos K., Fragia T., Natse T., Bartholomatos G., Karagianni A., Katsaris G., Christidou F., Bamichas G., Stangou M., Papagalanis N. The effect of long‐term intravenous high dose B‐complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients. J. Nephrol. 2002; 15(6)671–675, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sunder‐Plassmann G., Fodinger M., Buchmayer H., Papagiannopoulos M., Wojcik J., Kletzmayr J., Enzenberger B., Janata O., Winkelmayer W. C., Paul G., Auinger M., Barnas U., Horl W. H. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J. Am. Soc. Nephrol. 2000; 11(6)1106–1116
   PubMed Web of Science ®Google Scholar
• Kaplan L. N., Mamer O. A., Hoffer L. Parenteral vitamin B12 reduces hyperhomocysteinemia in end‐stage renal disease. J. Clin. Invest. Med. 2001; 24(1)5–11
   PubMed Web of Science ®Google Scholar
• Ducloux D., Aboubakr A., Motte G., Toubin G., Fournier V., Chalopin J. M., Drueke T., Massy Z. A. Hyperhomocysteinemia therapy in hemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol. Dial. Transplant. 2002; 17(5)865–870, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koyama K., Usami T., Takeuchi O., Morozumi K., Kimura G. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in hemodialysis patients receiving high‐dose folic acid supplementation. Nephrol. Dial. Transplant. 2002; 17(5)916–922, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Touam M., Zingraff J., Jungers P., Chadefaux‐Vekemans B., Drueke T., Massy Z. A. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int. 1999; 56(6)2292–2296, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lentz S. R. Homocysteine and vascular dysfunction. Life Sci. 1997; 61(13)1205–1215, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Shemin D., Verhoef P., Nadeau M. R., Jacques P. F., Selhub J., Dworkin L., Rosenberg I. H. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler. Thromb. Vasc. Biol. 1997; 17(11)2554–2558, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Arnadottir M., Brattstrom L., Simonsen O., Thysell H., Hultberg B., Andersson A., Nilsson‐Ehle P. The effect of high‐dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin. Nephrol. 1993; 40(4)236–240, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Billion S., Tribout B., Cadet E., Queinnec C., Rochette J., Wheatley P., Bataille P. Hyperhomocysteinemia, folate and vitamin B12 in unsupplemented hemodialysis patients: effect of oral therapy with folic acid and vitamin B12. Nephrol. Dial. Transplant. 2002; 17(3)455–461, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Trimarchi H., Schiel A., Freixas E., Diaz M. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron 2002; 91(1)58–63, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lacour B., Parry C., Drueke T., Touam M., Kreis H., Bailly M., Durand D. Pyridoxal 5′‐phosphate deficiency in uremic undialyzed, hemodialyzed, and non‐uremic kidney transplant patients. Clin. Chim. Acta 1983; 127(2)205–215, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Said H. M., Vaziri N. D., Kariger R. K., Hollander D. Intestinal absorption of 5‐methyltetrahydrofolate in experimental uremia. Acta Vitaminol. Enzymol. 1984; 6(4)339–346, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Tremblay R., Bonnardeaux A., Geadah D., Busque L., Lebrun M., Ouimet D., Leblanc M. Hyperhomocysteinemia in hemodialysis patients: effects of 12‐month supplementation with hydrosoluble vitamins. Kidney Int. 2000; 58(2)851–858, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buccianti G., Bamonti C. F., Patrosso C., Corghi E., Novembrino C., Baragetti I., Lando G., De Franceschi M., Maiolo A. T. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis. Am. J. Nephrol. 2001; 21(4)294–299, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Corghi E., Patrosso C., Bamonti F., Baragetti E., Novembrino C., Lando G., De Franceschi M., Buccianti G. Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients. G. Ital. Nefrol. 2002; 19(3)301–307, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar